Pentixapharm Holding Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Dirk Pleimes
Chief executive officer
€893.0k
Total compensation
| CEO salary percentage | 37.51% |
| CEO tenure | 2.5yrs |
| CEO ownership | n/a |
| Management average tenure | 1.5yrs |
| Board average tenure | 1.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -€16m |
| Dec 31 2025 | €893k | €335k | -€17m |
Compensation vs Market: Dirk's total compensation ($USD1.02M) is above average for companies of similar size in the US market ($USD655.15K).
Compensation vs Earnings: Insufficient data to compare Dirk's compensation with company performance.
CEO
Dirk Pleimes (51 yo)
Dr. Dirk Pleimes, MD is Chief Medical Officer of Pentixapharm Holding AG. Since January 2024 and Chief Executive Officer since March 01, 2025 and serves as Member of Management Board. Dr. Pleimes is Co-Fou...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group CEO | 2.5yrs | €893.00k | no data | |
| Member of Management Board & Chief Business Officer | 1.5yrs | €502.00k | no data | |
| Head of Finance & Controlling | no data | no data | no data | |
| Chief Technology Officer & Executive Board | less than a year | no data | no data | |
| Chief Scientific Officer | no data | no data | no data | |
| Head of Clinical Therapy | no data | no data | no data | |
| Head of R&D Operations | no data | no data | no data | |
| Head of Regulatory | no data | no data | no data |
Experienced Management: PTPD.F's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Supervisory Board | 1.4yrs | €144.00k | 0.20% $ 122.1k | |
| Vice Chairman of the Supervisory Board | 1.3yrs | no data | no data | |
| Member of the Supervisory Board | 1.8yrs | no data | no data | |
| Member of the Supervisory Board | 1yr | no data | no data | |
| Member of the Supervisory Board | 2.1yrs | no data | no data |
Experienced Board: PTPD.F's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/23 17:19 |
| End of Day Share Price | 2026/06/22 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pentixapharm Holding AG is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Roger Becker | BankM AG |
| Simon Keller | NuWays AG |